Difference between revisions of "Increase Access to Syringe Exchange Programs"

From SAFE Solutions
Jump to navigation Jump to search
user>Dmt7109
 
(80 intermediate revisions by 7 users not shown)
Line 1: Line 1:
<div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output"><div class="mw-parser-output">__NOTOC__ <div class="mw-parser-output"><div class="mw-parser-output">Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map or]] [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]] <div class="mw-parser-output"><div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block">&nbsp; __toc__
=Introductory Paragraph=
= Background =


Needle exchange programs (NEPs) are programs which distribute sanitized needles in exchange for contaminated or used needles. NEPs reduce the spread of blood borne diseases like HIV and Hepatitis C.
Needle exchange programs (NEPs) distribute sanitized needles in exchange for contaminated or used needles. NEPs reduce the spread of blood-borne diseases like HIV and Hepatitis C.  According to the CDC, syringe services programs (SSPs) are community-based prevention programs that can provide a range of services, including linkage to substance use disorder treatment; access to sterile syringes and injection equipment; and vaccination, testing, and referral to care and treatment for infectious diseases. <ref>https://www.cdc.gov/ssp/index.html</ref> NEPs and SSPs promote harm reduction to help protect the community by providing exchange programs and sterile supplies which help prevent the spread of infectious disease.


Many Organizations have endorsed needle exchange including NIH (National Institute of Health), CDC (Center for Disease Control), the American Bar Association, the American Medical Association, the American Psychological Association, the World Health Organization and others.<ref name="https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.1840360703" />
= Key Information =


The NIH estimates that in the United States, between fifteen and twenty percent of injection drug users have HIV and at least seventy percent have hepatitis C.<ref name="https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.1840360703" />&nbsp;<span style="line-height:normal"><span style="color:black">As such sharing needles has become the most common mode of HIV transmission among injection drug users (IDUs). In addition, used syringes and needles are a potential biohazard within which users primarily reside, and beyond it as well.</span></span>
Needle exchange programs have decades of evidence behind them - but not public support. <ref>https://opioidaction.org/2018/06/vox-a-new-study-shows-stigma-is-hurting-our-response-to-the-opioid-epidemic/</ref> Many organizations have endorsed needle exchange including NIH (National Institute of Health), CDC (Center for Disease Control), the American Bar Association, the American Medical Association, the American Psychological Association, and the World Health Organization. The NIH estimates that in the United States, between fifteen and twenty percent of injection drug users have HIV and at least seventy percent have Hepatitis C.<ref>https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.1840360703 </ref> As such, sharing needles has become the most common mode of HIV transmission among injection drug users. In addition, used syringes and needles are a potential biohazard. Harm reduction services such as the provision of sterile needles and syringes can effectively prevent Hepatitis C and HIV transmission among people who inject drugs, provided they are accessible and delivered at the required scale. Needle exchange programs help educate and inform injection drug users regarding injection practices, safety steps, non-sharing behavior, and other risk reduction methods. The CDC promotes SSPs and states that they "reduce HIV and HCV infections and are an effective component of comprehensive community-based prevention and intervention programs that provide additional services." <ref>https://www.cdc.gov/ssp/syringe-services-programs-factsheet.html</ref>


<span style="line-height:normal"><span style="color:black">Harm reduction services such as the provision of sterile needles and syringes can effectively prevent hepatitis C and HIV transmission among people who inject drugs, provided they are accessible and delivered at the required scale.</span></span>
There are currently several different models for syringe exchanges that have different advantages and limitations. The models include:


<span style="line-height:normal"><span style="color:black">Needle exchanges have been estimated to be a cost effective prevention practice. An analysis of the cost-effectiveness of a New York City needle syringe exchange estimated that the program would result in a baseline one year savings to the government of $1,300 to $3,000 per client. Another analysis by the CDC approximated that increasing access to clean syringes through an additional annual U.S. investment of $10 million would lead to (<ref name="https://www.cdc.gov/policy/hst/hi5/cleansyringes/index.html" />):</span></span>
*'''Primary and Secondary Needle and Syringe Programs''' are fixed sites which are typically located in areas with high levels of injecting drug use. They can be found in community centers, pharmacies, or specialized voluntary counseling and testing centers. Those who attend will be able to receive clean paraphernalia and safely dispose of used paraphernalia. <ref>https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes</ref>


*<span style="color:black"><span style="line-height:normal"><span style="tab-stops:list .5in"><span style="vertical-align:baseline">194 HIV infections averted in one year</span></span></span></span>
*'''Mobile or On-Call Service''' operate from a van or bus with clean needles which are distributed. Larger mobile programs typically provide testing and other healthcare services and operate along regular routes at fixed times, often at night when increased use occurs. Mobile services can also be smaller and choose to target specific populations. Mobile programs are more accessible to injection drug users and face less opposition from a community. <ref>https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes</ref>
*<span style="color:black"><span style="line-height:normal"><span style="tab-stops:list .5in"><span style="vertical-align:baseline">And A lifetime treatment cost savings of $75.8 million which would be a return on investment of $7.58 for every $1 spent</span></span></span></span>  


= Do Needle Exchanges Increase Drug Injection Rates? =
*'''Dispensing Machine Distribution.''' Australia and countries in Europe have adopted a newer strategy and have begun to use syringe vending machines. They use non-currency tokens which are distributed by outreach workers to injection drug users in return for harm reduction packs. Australia’s machines include needles, syringes, alcohol swabs, cotton, wool, sterile water, and spoons. Others sometimes contain educational materials. Typically, these machines act in conjunction with fixed sites which provide needles and syringes 24 hours a day, 7 days a week. A clinical trial found that this strategy can be highly effective for reaching populations who are most marginalized or otherwise hard to reach. <ref>https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes</ref>


<span style="line-height:normal"><span style="font-family:" arial",sans-serif"=""><span style="color:black">A review of needle exchange done by the office of the Surgeon General and the assistant secretary for health found that needle exchange did not cause an increase in drug injection, but rather typically led to a decrease in injection rates when these programs were used.<ref name="http://www.csdp.org/research/surgeongennex.pdf" /></span></span></span>
*'''Peer Service Distribution Networks.''' This is a strategy in which clients of needle exchanges provide services to their peers, distributing needles, syringes, and associated injection equipment. These clients are trained to assist peers to access exchangers, to distribute information about safer drug use and safer sex, and to facilitate referrals to other health services. This model, in addition to disseminating safer practices and helping make needle exchange programs reach a larger population, may have the psychological impact of making interventions more effective. <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241304/</ref>


Another study sought to answer the question "is the number of needles distributed from needle exchange programs proportionate to the number of needles returned to needle exchange programs?" It was found that in the United States the return rate was on average over 90% (~315,000 needles distributed and ~283,000 needles returned).&nbsp;<ref name="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/" />
*'''Prison-Based Facilities''' are still a newly developing practice, only used in 3 of 24 UN countries that have needle exchange programs for the public. <ref>http://blogs.biomedcentral.com/on-health/wp-content/uploads/sites/8/2016/10/Prison-based-needle-and-syringe-programmes-PNSP-final.pdf</ref> They meet a high need because prison populations have more cases of Hepatitis C and HIV than the average population. <ref>http://blogs.biomedcentral.com/on-health/wp-content/uploads/sites/8/2016/10/Prison-based-needle-and-syringe-programmes-PNSP-final.pdf</ref>


This finding has been further substantiated by another review which found that supplying IDUs (Injecting Drug Users) with clean or sanitized needles does not lead to more "dirty" needles in a community.&nbsp;<ref name="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/" />
= Relevant Research =


= Different Models for Syringe Exchanges =
*'''Three Studies Documenting Positive Results.''' A review of needle exchange done by the office of the Surgeon General and the assistant secretary for health found that needle exchange did not cause an increase in drug injection, but rather typically led to a decrease in injection rates when these programs were used.<ref>http://www.csdp.org/research/surgeongennex.pdf</ref> Another study sought to answer the question "is the number of needles distributed from needle exchange programs proportionate to the number of needles returned to needle exchange programs?" It was found that in the United States the return rate was on average over 90% (~315,000 needles distributed and ~283,000 needles returned). <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/</ref> The National Research Council report on the topic states: “The need for and value of targeted education and behavior modification efforts directed at injection drug users at risk of HIV transmission have been clearly demonstrated in programs that do not include needle exchange.” <ref>https://www.ncbi.nlm.nih.gov/books/NBK232350/</ref>


<span style="line-height:normal"><span style="font-family:" arial",sans-serif"=""><span style="color:black">There are currently several different models for syringe exchanges that have different advantages and limitations. The models include:</span></span></span>
*'''Two Cost-Benefit Analyses.''' Needle exchanges have been projected to be a cost-effective prevention practice. An analysis of the cost-effectiveness of a New York City needle syringe exchange estimated that the program would result in a baseline one year savings to the government of $1,300 to $3,000 per client. <ref>Belani, H.K. and P.A. Muennig, Cost-effectiveness of needle and syringe exchange for the prevention of HIV in New York City. Journal of HIV/AIDS & Social Services, 2008. 7(3): p. 229-240.</ref> Another analysis estimated that increasing access to clean syringes through an additional annual U.S. investment of $10 million would lead to a decrease of 194 HIV infections per year and a lifetime treatment cost savings of $75.8 million which would be a return on investment of $7.58 for every $1 spent. <ref>Nguyen, T.Q., et al., Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment. AIDS and Behavior, 2014. 18(11): p. 2144-2155.</ref>  


<span style="line-height:normal"><span style="font-family:" arial",sans-serif"=""><span style="color:black">Primary and secondary needle and syringe programs (also now as "standalone services"):</span></span></span>
*'''Meta-Analysis on Community Impact.''' This literature review found that supplying injecting drug users with clean or sanitized needles does not lead to more "dirty" needles in a community. <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/</ref>


*<span style="color:black"><span style="line-height:normal"><span style="tab-stops:list .5in"><span style="vertical-align:baseline">They are fixed sites that are typically located in areas with high levels of injecting drug use.</span></span></span></span>
= Impactful Federal, State, and Local Policies =
*<span style="color:black"><span style="line-height:normal"><span style="tab-stops:list .5in"><span style="vertical-align:baseline">They can be located in many different areas such as community centers, pharmacies, or specialized voluntary counselling and testing centers.</span></span></span></span>
*<span style="font-size:11.0pt"><span style="line-height:107%"><span style="font-family:" calibri",sans-serif"=""><span style="color:black">Those who attend will be able to receive clean paraphernalia, and dispose safely of used paraphernalia. Also typically At fixed sites, additional services are offered such as healthcare alongside testing and or counselling for HIV and other blood-borne viruses&nbsp;<ref name="https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes" /></span></span></span></span>


&nbsp;
* '''The Consolidated Appropriations Act, 2016''' restricted the use of federal funds for programs distributing sterile needles or syringes for HHS programs. However, HHS also provides a guidance document that outlines how federal funds may be used for other aspects of SSPs based on evidence of a demonstrated need, in consultation with CDC. <ref>https://www.congress.gov/114/bills/hr2029/BILLS-114hr2029enr.pdf</ref>


Hepatitis C is more than three time more prevalent among people who inject drugs than HIV. In most countries, more than half the people who inject drugs are living with Hepatitis C.<sup class="reference">[1]</sup> In addition, the number of undiagnosed cases is estimated to be very high: between 50 and 90 percent of people living with Hepatitis C may be unaware of their infection. In countries with repressive drug laws, Hep C testing rates among people who use drugs are often even lower largely due to stigmatisation in health care settings, fear of arrest, or the unavailability of treatment and testing.
* Currently each state has their own laws surrounding syringe exchange programs.  


&nbsp; Harm reduction services such as the provision of sterile needles and syringes can effectively prevent hepatitis C transmission among people who inject drugs, provided they are accessible and delivered at the required scale.<sup class="reference">[2]</sup>
* '''A Comprehensive Guide to Syringe Services Programs and Syringe Possession Laws'''<ref>https://pdaps.org/datasets/syringe-services-programs-laws</ref> delineates how syringe possession polices impact ease of access to sterile syringes for injection drug users.


&nbsp; While chronic Hepatitis C is not a death sentence, it creates a slew of long term problems. About one in five people will develop more progressive liver damage with fibrosis (scarring of the liver). Hep C can also cause cirrhosis to the point where the scarring diminishes liver function. Aside from discomfort, this slow burn inflammation can exacerbate other conditions, and in up to five percent of people lead to the kind of full liver failure that requires an organ transplant.<sup class="reference">[3]</sup><br/> &nbsp;
=Available Tools & Resources=


&nbsp; Prevention is a extraordinarily cost effective. In 2013 the FDA approved a new class of direct-acting antiviral drugs for Hep C, which can clear the body 90% of the time. However, a course of treatment for either of the most common medications, Viekira Pak or Harvoni, can cost $85,000 to $94,500. It would cost more than 10 percent of all the medical care in the country to treat the roughly 3.5 million Americans estimated to be infected with Hep C.<sup class="reference">[4]</sup> Hep C treatment is costly to public programs as well. In 2015, Medicaid spent about $2.2 billion on just one Hep C medication, Harvoni, made by Gilead Sciences. This Hep C treatment cost more than any other individual medication.<sup class="reference">[5]</sup>
*'''SAFE Project:'''
**'''"Have A Safety Plan"''' is a SAFE Project resource that instructs drug users on how to create a safety plan to prevent overdoses.<ref>https://www.safeproject.us/safety-plan/</ref>
**See the wiki titled "The Linkage Between Syringe Use and Infectious Disease" for more detailed information on drug use and the concern for those with an SUD catching or spreading infectious diseases.<ref>https://www.yoursafesolutions.us/wiki/The_Linkage_Between_Syringe_Use_and_Infectious_Disease/</ref>


&nbsp; Sharing needles has become the most common mode of HIV transmission among injection drug users (IDUs). IN turn, IDUs often spread HIV to other, non-injecting populations through sexual relations. In addition, used syringes and needles are a potential biohazard throughout the geographic area within which IDUs primarily reside, and beyond it as well.<sup class="reference">[6]</sup>
*'''The World Health Organization''' has published a "Guide to Starting and Managing Needle and Syringe Programs." <ref>https://www.unodc.org/documents/hiv-aids/NSP-GUIDE-WHO-UNODC.pdf</ref>


&nbsp; Studies have found that needle exchange programs also reduce pollution.
*'''CDC''' provides a fact sheet on harm reduction to promote prevention of transmission of infectious disease, including blood-borne infections. <ref>https://www.cdc.gov/ssp/syringe-services-programs-factsheet.html</ref> They have published a document titled "Syringe Services Programs: A Technical Package of Effective Strategies and Approaches for Planning, Design, and Implementation."  <ref>https://www.cdc.gov/ssp/docs/SSP-Technical-Package.pdf</ref> They have also provided guidance to state, local, tribal, and territorial health departments to determine if they have adequately demonstrated need for SSPs according to federal law. <ref>https://www.cdc.gov/ssp/determination-of-need-for-ssp.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fhiv%2Frisk%2Fssps.html</ref>


&nbsp;
*'''SAMHSA''' provides specific guidance for Minority HIV/AIDS Initiative (MAI) Programs that are implementing SSPs. <ref>https://www.samhsa.gov/sites/default/files/grants/ssp-guidance-for-hiv-grants.pdf</ref>


== &nbsp; ==
*'''The National Association of County Health Officials (NACCHO).''' In collaboration with the CDC and in partnership with the University of Washington, NACCHO provides funding and technical assistance to local health departments and community-based SSPs. <ref>https://www.naccho.org/blog/articles/funding-opportunity-building-capacity-for-harm-reduction-monitoring-evaluation</ref>
<div class="mw-parser-output">
== Different Models for Syringe Exchanges ==


There are several different modesl for syringe exchanges that have different advantages and limitations.&nbsp; The website for the North Carolina Harm Reduction Coalition (NCHRC) describes these in [http://www.nchrc.org/syringe-exchange/syringe-exchange-models/ their website]. The models include:&nbsp;
*'''The North American Syringe Exchange Network''' provides a directory of locations for SSPs. <ref>https://www.nasen.org</ref>


*Fixed-site Exchanges
*'''The Comer Family Foundation''' provides harm reduction grants for free sterile syringes. <ref>https://www.comerfamilyfoundation.org/syringe-service-program</ref> It has also published "A Guide to Establishing Syringe Services Programs in Rural, At-Risk Areas." <ref>https://www.comerfamilyfoundation.org/img/A-Guide-to-Establishing-Syringe-Services-Programs-in-Rural-At-Risk-Areas.pdf</ref>
*Mobile/Street-based Exchanges or Vehicle-based Exchanges
*Home Delivery or Peer-based Exchanges
*Integrated Syringe Exchanges<ref>http://www.nchrc.org/syringe-exchange/syringe-exchange-models/</ref><br/> &nbsp;
</div>  
= Return Rates of Needle Exchanges =


One prominent study sought to answer the question "is the number of needles distributed from NEPs proportionate to the number of needles returned to NEPs?"<br/> &nbsp; Overall, the global return rate for NEPs was 90% based on a total distribution of 11,971,584 needles (needles out) and 10,793,270 needles returned to the NEPs (needles in). The US return rate was over 90% (315,942 needles distributed, 282,897 needles returned).<sup class="reference">[7]</sup>
*'''The Syringe Access Fund''' awards grants in two categories: 1) SSPs providing direct services, and 2) harm reduction organizations at the local, state and federal levels conducting community education and mobilization activities focused on legalizing or SSPs and other health interventions for people who use drugs. <ref>https://aidsunited.org/new-funding-opportunity-syringe-access-fund/</ref>


&nbsp; The evidence regarding return rates presented in this this study makes it clear that supplying IDUs (Injecting Drug Users) with clean needles does not lead to more "dirty" needles in any given community. While NEP critics argue that distribution of needles to IDUs does nothing more than increase the number of needles in circulation, the evidence presented here does not support that assertion.<br/> <br/> &nbsp;
= Promising Practices =


&nbsp;
*'''Miami, Florida.''' In three years of operation, Miami's pilot program pulled more than a quarter million used needles out of circulation. By handing out Narcan at the needle exchange, it has helped prevent more than a thousand overdoses. The program also offers clients testing for HIV and Hepatitis C and connects people to medical care and rehabilitation services. <ref>https://www.npr.org/sections/health-shots/2019/06/27/725462715/key-florida-republicans-now-say-yes-to-clean-needles-for-drug-users</ref>


= Peer-Delivered Needle Exchanges =
*'''Philadelphia, Pennsylvania.''' A case study found that Prevention Point, a needle exchange located in Philadelphia helped prevent 10,000 people from contracting HIV over 10 Years. The researchers from George Washington University estimate that the total lifetime taxpayer savings from this needle exchange averting 10,000 cases of HIV saved them $1.8 billion. <ref>https://www.phillymag.com/news/2019/10/31/prevention-point-syringe-exchange-study/</ref>


One option being used in King County, WA is to use peers to bring new syringes to people injecting drugs. (Find out more.)<br/> [http://harmreduction.org/wp-content/uploads/2012/11/pdse-toolkit-with-links.pdf [2]]<br/> [https://www.talkingdrugs.org/the-benefits-of-peer-delivered-syringe-exchange-programs [3]]<br/> &nbsp; Research on the [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241304/ influence of peer-delivered syringe exchanges on mental health]
*'''Scott County, Indiana.''' Before Scott County set up its syringe exchange program in 2015, this rural county was seeing 10-20 new HIV cases every week. Almost immediately, the number of new cases was slowed to 1-2 a month.
 
&nbsp;
 
= &nbsp; =
 
= Success Stories =
 
== Scott County, Indiana ==
 
Before Scott County set up its syringe exchange (plus more) program in 2015, the rural county in Indiana was seeing 10-20 new HIV cases every week. Almost immediately after, the number of new cases was slowed to 1-2 a month.<sup class="reference">[8]</sup>
 
&nbsp;
 
= Tools & Resources =
 
[[TR_-_Increase_Access_to_Needle_Exchanges|TR - Increase Access to Needle Exchanges]]
 
= Scorecard Building =
 
[[PO_-_Increase_Access_to_Needle_Exchanges|Potential Objective Details]]<br/> [[PM_-_Increase_Access_to_Needle_Exchanges|Potential Measures and Data Sources]]<br/> [[PA_-_Increase_Access_to_Needle_Exchanges|Potential Actions and Partners]]
 
= Resources to Investigate =
 
[[RTI_-_Increase_Access_to_Needle_Exchanges|More RTI on Increase Access to Needle Exchanges]]<br/> <br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">PAGE MANAGER</span>:''' </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[insert name here]</span><br/> <span style="background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px">'''<span style="color: #4d4d4d">SUBJECT MATTER EXPERT</span>''': </span><span style="background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px">[fill out table below]</span>
 
{| class="wiki_table"
|-
| '''Reviewer'''
| '''Date'''
| '''Comments'''
|-
| &nbsp;
| &nbsp;
| &nbsp;
|}


= Sources =
= Sources =


----
----
 
</div>
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [4]]
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [5]]
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [6]]
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [7]]
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [8]]
#[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/ [9]]
#[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/ [10]]
#[http://sideeffectspublicmedia.org/post/indiana-law-makes-harm-reduction-opioid-addiction-yearly-battle [11]]
</div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>  
[[Category:SAFE-Full Spectrum Prevention]]
[[Category:SAFE-Full Spectrum Prevention]]

Latest revision as of 11:31, 23 October 2024

Introductory Paragraph

Needle exchange programs (NEPs) distribute sanitized needles in exchange for contaminated or used needles. NEPs reduce the spread of blood-borne diseases like HIV and Hepatitis C. According to the CDC, syringe services programs (SSPs) are community-based prevention programs that can provide a range of services, including linkage to substance use disorder treatment; access to sterile syringes and injection equipment; and vaccination, testing, and referral to care and treatment for infectious diseases. [1] NEPs and SSPs promote harm reduction to help protect the community by providing exchange programs and sterile supplies which help prevent the spread of infectious disease.

Key Information

Needle exchange programs have decades of evidence behind them - but not public support. [2] Many organizations have endorsed needle exchange including NIH (National Institute of Health), CDC (Center for Disease Control), the American Bar Association, the American Medical Association, the American Psychological Association, and the World Health Organization. The NIH estimates that in the United States, between fifteen and twenty percent of injection drug users have HIV and at least seventy percent have Hepatitis C.[3] As such, sharing needles has become the most common mode of HIV transmission among injection drug users. In addition, used syringes and needles are a potential biohazard. Harm reduction services such as the provision of sterile needles and syringes can effectively prevent Hepatitis C and HIV transmission among people who inject drugs, provided they are accessible and delivered at the required scale. Needle exchange programs help educate and inform injection drug users regarding injection practices, safety steps, non-sharing behavior, and other risk reduction methods. The CDC promotes SSPs and states that they "reduce HIV and HCV infections and are an effective component of comprehensive community-based prevention and intervention programs that provide additional services." [4]

There are currently several different models for syringe exchanges that have different advantages and limitations. The models include:

  • Primary and Secondary Needle and Syringe Programs are fixed sites which are typically located in areas with high levels of injecting drug use. They can be found in community centers, pharmacies, or specialized voluntary counseling and testing centers. Those who attend will be able to receive clean paraphernalia and safely dispose of used paraphernalia. [5]
  • Mobile or On-Call Service operate from a van or bus with clean needles which are distributed. Larger mobile programs typically provide testing and other healthcare services and operate along regular routes at fixed times, often at night when increased use occurs. Mobile services can also be smaller and choose to target specific populations. Mobile programs are more accessible to injection drug users and face less opposition from a community. [6]
  • Dispensing Machine Distribution. Australia and countries in Europe have adopted a newer strategy and have begun to use syringe vending machines. They use non-currency tokens which are distributed by outreach workers to injection drug users in return for harm reduction packs. Australia’s machines include needles, syringes, alcohol swabs, cotton, wool, sterile water, and spoons. Others sometimes contain educational materials. Typically, these machines act in conjunction with fixed sites which provide needles and syringes 24 hours a day, 7 days a week. A clinical trial found that this strategy can be highly effective for reaching populations who are most marginalized or otherwise hard to reach. [7]
  • Peer Service Distribution Networks. This is a strategy in which clients of needle exchanges provide services to their peers, distributing needles, syringes, and associated injection equipment. These clients are trained to assist peers to access exchangers, to distribute information about safer drug use and safer sex, and to facilitate referrals to other health services. This model, in addition to disseminating safer practices and helping make needle exchange programs reach a larger population, may have the psychological impact of making interventions more effective. [8]
  • Prison-Based Facilities are still a newly developing practice, only used in 3 of 24 UN countries that have needle exchange programs for the public. [9] They meet a high need because prison populations have more cases of Hepatitis C and HIV than the average population. [10]

Relevant Research

  • Three Studies Documenting Positive Results. A review of needle exchange done by the office of the Surgeon General and the assistant secretary for health found that needle exchange did not cause an increase in drug injection, but rather typically led to a decrease in injection rates when these programs were used.[11] Another study sought to answer the question "is the number of needles distributed from needle exchange programs proportionate to the number of needles returned to needle exchange programs?" It was found that in the United States the return rate was on average over 90% (~315,000 needles distributed and ~283,000 needles returned). [12] The National Research Council report on the topic states: “The need for and value of targeted education and behavior modification efforts directed at injection drug users at risk of HIV transmission have been clearly demonstrated in programs that do not include needle exchange.” [13]
  • Two Cost-Benefit Analyses. Needle exchanges have been projected to be a cost-effective prevention practice. An analysis of the cost-effectiveness of a New York City needle syringe exchange estimated that the program would result in a baseline one year savings to the government of $1,300 to $3,000 per client. [14] Another analysis estimated that increasing access to clean syringes through an additional annual U.S. investment of $10 million would lead to a decrease of 194 HIV infections per year and a lifetime treatment cost savings of $75.8 million which would be a return on investment of $7.58 for every $1 spent. [15]
  • Meta-Analysis on Community Impact. This literature review found that supplying injecting drug users with clean or sanitized needles does not lead to more "dirty" needles in a community. [16]

Impactful Federal, State, and Local Policies

  • The Consolidated Appropriations Act, 2016 restricted the use of federal funds for programs distributing sterile needles or syringes for HHS programs. However, HHS also provides a guidance document that outlines how federal funds may be used for other aspects of SSPs based on evidence of a demonstrated need, in consultation with CDC. [17]
  • Currently each state has their own laws surrounding syringe exchange programs.
  • A Comprehensive Guide to Syringe Services Programs and Syringe Possession Laws[18] delineates how syringe possession polices impact ease of access to sterile syringes for injection drug users.

Available Tools & Resources

  • SAFE Project:
    • "Have A Safety Plan" is a SAFE Project resource that instructs drug users on how to create a safety plan to prevent overdoses.[19]
    • See the wiki titled "The Linkage Between Syringe Use and Infectious Disease" for more detailed information on drug use and the concern for those with an SUD catching or spreading infectious diseases.[20]
  • The World Health Organization has published a "Guide to Starting and Managing Needle and Syringe Programs." [21]
  • CDC provides a fact sheet on harm reduction to promote prevention of transmission of infectious disease, including blood-borne infections. [22] They have published a document titled "Syringe Services Programs: A Technical Package of Effective Strategies and Approaches for Planning, Design, and Implementation." [23] They have also provided guidance to state, local, tribal, and territorial health departments to determine if they have adequately demonstrated need for SSPs according to federal law. [24]
  • SAMHSA provides specific guidance for Minority HIV/AIDS Initiative (MAI) Programs that are implementing SSPs. [25]
  • The National Association of County Health Officials (NACCHO). In collaboration with the CDC and in partnership with the University of Washington, NACCHO provides funding and technical assistance to local health departments and community-based SSPs. [26]
  • The North American Syringe Exchange Network provides a directory of locations for SSPs. [27]
  • The Comer Family Foundation provides harm reduction grants for free sterile syringes. [28] It has also published "A Guide to Establishing Syringe Services Programs in Rural, At-Risk Areas." [29]
  • The Syringe Access Fund awards grants in two categories: 1) SSPs providing direct services, and 2) harm reduction organizations at the local, state and federal levels conducting community education and mobilization activities focused on legalizing or SSPs and other health interventions for people who use drugs. [30]

Promising Practices

  • Miami, Florida. In three years of operation, Miami's pilot program pulled more than a quarter million used needles out of circulation. By handing out Narcan at the needle exchange, it has helped prevent more than a thousand overdoses. The program also offers clients testing for HIV and Hepatitis C and connects people to medical care and rehabilitation services. [31]
  • Philadelphia, Pennsylvania. A case study found that Prevention Point, a needle exchange located in Philadelphia helped prevent 10,000 people from contracting HIV over 10 Years. The researchers from George Washington University estimate that the total lifetime taxpayer savings from this needle exchange averting 10,000 cases of HIV saved them $1.8 billion. [32]
  • Scott County, Indiana. Before Scott County set up its syringe exchange program in 2015, this rural county was seeing 10-20 new HIV cases every week. Almost immediately, the number of new cases was slowed to 1-2 a month.

Sources


  1. https://www.cdc.gov/ssp/index.html
  2. https://opioidaction.org/2018/06/vox-a-new-study-shows-stigma-is-hurting-our-response-to-the-opioid-epidemic/
  3. https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.1840360703
  4. https://www.cdc.gov/ssp/syringe-services-programs-factsheet.html
  5. https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes
  6. https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes
  7. https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes
  8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241304/
  9. http://blogs.biomedcentral.com/on-health/wp-content/uploads/sites/8/2016/10/Prison-based-needle-and-syringe-programmes-PNSP-final.pdf
  10. http://blogs.biomedcentral.com/on-health/wp-content/uploads/sites/8/2016/10/Prison-based-needle-and-syringe-programmes-PNSP-final.pdf
  11. http://www.csdp.org/research/surgeongennex.pdf
  12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/
  13. https://www.ncbi.nlm.nih.gov/books/NBK232350/
  14. Belani, H.K. and P.A. Muennig, Cost-effectiveness of needle and syringe exchange for the prevention of HIV in New York City. Journal of HIV/AIDS & Social Services, 2008. 7(3): p. 229-240.
  15. Nguyen, T.Q., et al., Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment. AIDS and Behavior, 2014. 18(11): p. 2144-2155.
  16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/
  17. https://www.congress.gov/114/bills/hr2029/BILLS-114hr2029enr.pdf
  18. https://pdaps.org/datasets/syringe-services-programs-laws
  19. https://www.safeproject.us/safety-plan/
  20. https://www.yoursafesolutions.us/wiki/The_Linkage_Between_Syringe_Use_and_Infectious_Disease/
  21. https://www.unodc.org/documents/hiv-aids/NSP-GUIDE-WHO-UNODC.pdf
  22. https://www.cdc.gov/ssp/syringe-services-programs-factsheet.html
  23. https://www.cdc.gov/ssp/docs/SSP-Technical-Package.pdf
  24. https://www.cdc.gov/ssp/determination-of-need-for-ssp.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fhiv%2Frisk%2Fssps.html
  25. https://www.samhsa.gov/sites/default/files/grants/ssp-guidance-for-hiv-grants.pdf
  26. https://www.naccho.org/blog/articles/funding-opportunity-building-capacity-for-harm-reduction-monitoring-evaluation
  27. https://www.nasen.org
  28. https://www.comerfamilyfoundation.org/syringe-service-program
  29. https://www.comerfamilyfoundation.org/img/A-Guide-to-Establishing-Syringe-Services-Programs-in-Rural-At-Risk-Areas.pdf
  30. https://aidsunited.org/new-funding-opportunity-syringe-access-fund/
  31. https://www.npr.org/sections/health-shots/2019/06/27/725462715/key-florida-republicans-now-say-yes-to-clean-needles-for-drug-users
  32. https://www.phillymag.com/news/2019/10/31/prevention-point-syringe-exchange-study/